Clinical Drug Investigation

2.9k papers and 36.7k indexed citations i.

About

The 2.9k papers published in Clinical Drug Investigation in the last decades have received a total of 36.7k indexed citations. Papers published in Clinical Drug Investigation usually cover Surgery (511 papers), Pharmacology (441 papers) and Cardiology and Cardiovascular Medicine (424 papers) specifically the topics of Blood Pressure and Hypertension Studies (179 papers), Diabetes Treatment and Management (150 papers) and Asthma and respiratory diseases (135 papers). The most active scholars publishing in Clinical Drug Investigation are Mona Darwish, Kenneth C. Lasseter, Ignacio Tagarro, Andrea Marcellusi and Giovambattista De Sarro.

In The Last Decade

Fields of papers published in Clinical Drug Investigation

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Clinical Drug Investigation. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Clinical Drug Investigation

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Clinical Drug Investigation. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Clinical Drug Investigation with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025